Drug Database
Back to search

Poland· PL-100499073

Atywia

A dienogest und ethinylestradiol product containing ethinylestradiolum + dienogestum, registered in Poland by Medezin Sp. z o.o.. The same ATC class is registered in 9 of our 19 countries.

ATC G03AA16

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedAtywiaATCG03AA16REGISTER NO.PL-100499073PACKS LISTED3CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about ethinylestradiolum + dienogestumAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Dienogest und ethinylestradiol is registered in 9 of 19 countries.

Countries holding a registration under ATC G03AA16 (dienogest und ethinylestradiol), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 6 of them publish a price we can compare per daily dose
Search dienogest und ethinylestradiol products by name

Dienogest und ethinylestradiol · ATC G03AA16

9 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

URPL (Poland)
Active substance
Ethinylestradiolum + Dienogestum
Manufacturer
Medezin Sp. z o.o.
Country
Poland (PL)
ATC code
G03AA16
ATC class
Dienogest und Ethinylestradiol
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 3

  • gtin
    05909991549121
  • gtin
    05909991549138
  • gtin
    05909991549145

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

1 interaction on record for dienogest und ethinylestradiol.

Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check dienogest und ethinylestradiol against other medicinesHow interaction checks work

Dienogest und ethinylestradiol · interactions on record

1 record

1 more interaction with mechanism and management, from a commercially licensed source.

Sign in to check
Mechanism and what to do, in the interaction check
Interaction register. Grades as the source publishes them.

Same medicine, other countries

Dienogest und ethinylestradiol in 9 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All dienogest und ethinylestradiol products

Authorised across Europe · EMA

The same active substance is authorised in 22 EEA countries. Names it is sold under:

  • Austria · Dienorette, Dienovel
  • Belgium · Dienobel, Louise
  • Bulgaria · Жанин
  • Czechia · Aidee, Ayreen
  • Germany · Amobena, Aristelle
  • Denmark · Yana
  • Estonia · Ammily, Jeanine
  • Spain · Adieris, Ailyn Diario
  • Finland · Yanulez
  • France · Misolfa
  • United Kingdom (Northern Ireland) · Dienogest/Ethinylestradiol, Serisima
  • Croatia · Donella
  • Hungary · Dienille, Mistral
  • Ireland · Mistra, Raener
  • Italy · Cemisiana, Dienestra
  • Lithuania · Ammily, Jeanine
  • Luxembourg · Dienobel, Louise
  • Latvia · Ammily, Jeanine
  • Netherlands · Ethinylestradiol/Dienogest Mithra, Misolfa
  • Norway · Yana
  • Portugal · Denille, Dienogest + Etinilestradiol Leon Farma
  • Slovakia · Aidee, Dienorette

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/fb2a5ac7-ea6d-4fd0-a6ff-bc2e89ce56f7
GET /v1/drugs/fb2a5ac7-ea6d-4fd0-a6ff-bc2e89ce56f7?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tabletki powlekane",
  "source": "urpl",
  "strength": "0,03 mg + 2 mg",
  "packaging": "05909991549121 ¦ Rp ¦ 156845\n63 tabl.\n05909991549138 ¦ Rp ¦ 156846\n21 tabl.\n05909991549145 ¦ Rp ¦ 156847\n126 tabl.",
  "substance": "Ethinylestradiolum 0.03 mg + Dienogestum 2 mg",
  "common_name": "Ethinylestradiolum + Dienogestum",
  "pl_product_id": "100499073",
  "pozwolenie_nr": "248/24",
  "auth_procedure": "IR",
  "authorisation_validity": "2029-06-18"
}
API referenceMCP serverPlans

See everything about dienogest und ethinylestradiol.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console